Literature DB >> 27942750

The role of caloric load and mitochondrial homeostasis in the regulation of the NLRP3 inflammasome.

Javier Traba1, Michael N Sack2.   

Abstract

Sterile inflammation is a cornerstone of immune activation in obesity and type 2 Diabetes Mellitus. The molecular underpinnings of this inflammation include nutrient excess-mediated activation of the innate immune NLRP3 inflammasome. At the same time, disruption of mitochondrial integrity is emerging as an integral control node in NLRP3 inflammasome activation and is also associated with caloric overload conditions including obesity and diabetes. Conversely, caloric restriction and fasting mimetic interventions alleviate these caloric excess-linked diseases and reduce inflammation and the NLRP3 inflammasome. The objective of this review is to integrate the findings linking mitochondrial integrity to the activation of the NLRP3 inflammasome and to evaluate how caloric restriction or caloric restriction mimetic compounds may play a role in attenuating the NLRP3 inflammasome and sterile inflammation.

Entities:  

Keywords:  Mitochondria; NLRP3 inflammasome; Obesity; Sirtuins; Sterile inflammation

Mesh:

Substances:

Year:  2016        PMID: 27942750      PMCID: PMC5391300          DOI: 10.1007/s00018-016-2431-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  136 in total

1.  Genomic instability and aging-like phenotype in the absence of mammalian SIRT6.

Authors:  Raul Mostoslavsky; Katrin F Chua; David B Lombard; Wendy W Pang; Miriam R Fischer; Lionel Gellon; Pingfang Liu; Gustavo Mostoslavsky; Sonia Franco; Michael M Murphy; Kevin D Mills; Parin Patel; Joyce T Hsu; Andrew L Hong; Ethan Ford; Hwei-Ling Cheng; Caitlin Kennedy; Nomeli Nunez; Roderick Bronson; David Frendewey; Wojtek Auerbach; David Valenzuela; Margaret Karow; Michael O Hottiger; Stephen Hursting; J Carl Barrett; Leonard Guarente; Richard Mulligan; Bruce Demple; George D Yancopoulos; Frederick W Alt
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

2.  Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice.

Authors:  Kathryn F Mills; Shohei Yoshida; Liana R Stein; Alessia Grozio; Shunsuke Kubota; Yo Sasaki; Philip Redpath; Marie E Migaud; Rajendra S Apte; Koji Uchida; Jun Yoshino; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2016-10-27       Impact factor: 27.287

3.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

4.  Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.

Authors:  Lei Jiang; Lei Zhang; Kai Kang; Dongsheng Fei; Rui Gong; Yanhui Cao; Shangha Pan; Mingran Zhao; Mingyan Zhao
Journal:  Biomed Pharmacother       Date:  2016-09-16       Impact factor: 6.529

5.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

6.  Inflammasome is a central player in the induction of obesity and insulin resistance.

Authors:  Rinke Stienstra; Janna A van Diepen; Cees J Tack; Md Hasan Zaki; Frank L van de Veerdonk; Deshani Perera; Geoffrey A Neale; Guido J Hooiveld; Anneke Hijmans; Irene Vroegrijk; Sjoerd van den Berg; Johannes Romijn; Patrick C N Rensen; Leo A B Joosten; Mihai G Netea; Thirumala-Devi Kanneganti
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

7.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging.

Authors:  Yun-Hee Youm; Ryan W Grant; Laura R McCabe; Diana C Albarado; Kim Yen Nguyen; Anthony Ravussin; Paul Pistell; Susan Newman; Renee Carter; Amanda Laque; Heike Münzberg; Clifford J Rosen; Donald K Ingram; J Michael Salbaum; Vishwa Deep Dixit
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

8.  SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes.

Authors:  Takeshi Yoshizaki; Jill C Milne; Takeshi Imamura; Simon Schenk; Noriyuki Sonoda; Jennie L Babendure; Juu-Chin Lu; Jesse J Smith; Michael R Jirousek; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

Review 9.  Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

10.  K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells.

Authors:  J R Yaron; S Gangaraju; M Y Rao; X Kong; L Zhang; F Su; Y Tian; H L Glenn; D R Meldrum
Journal:  Cell Death Dis       Date:  2015-10-29       Impact factor: 8.469

View more
  9 in total

Review 1.  Mitochondrial fidelity and metabolic agility control immune cell fate and function.

Authors:  Michael N Sack
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

2.  A Pilot Study To Investigate the Immune-Modulatory Effects of Fasting in Steroid-Naive Mild Asthmatics.

Authors:  Kim Han; An Nguyen; Javier Traba; Xianglan Yao; Maryann Kaler; Rebecca D Huffstutler; Stewart J Levine; Michael N Sack
Journal:  J Immunol       Date:  2018-07-18       Impact factor: 5.422

3.  Nutritional psychoneuroimmunology: Is the inflammasome a critical convergence point for stress and nutritional dysregulation?

Authors:  Albert E Towers; Gregory G Freund
Journal:  Curr Opin Behav Sci       Date:  2019-02-23

4.  Function of NLRP3 in the Pathogenesis and Development of Diabetic Nephropathy.

Authors:  Ying Fu; Nannan Wu; Dong Zhao
Journal:  Med Sci Monit       Date:  2017-08-11

Review 5.  Metabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives.

Authors:  Palma Lamonaca; Giulia Prinzi; Aliaksei Kisialiou; Vittorio Cardaci; Massimo Fini; Patrizia Russo
Journal:  Mar Drugs       Date:  2017-03-20       Impact factor: 5.118

6.  Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.

Authors:  Jing Wu; Komudi Singh; Amy Lin; Allison M Meadows; Kaiyuan Wu; Vivian Shing; Maximilian Bley; Shahin Hassanzadeh; Rebecca D Huffstutler; Mark S Schmidt; Luz P Blanco; Rong Tian; Charles Brenner; Mehdi Pirooznia; Mariana J Kaplan; Michael N Sack
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 19.456

7.  ASC Regulates Subcutaneous Adipose Tissue Lipogenesis and Lipolysis via p53/AMPKα Axis.

Authors:  Hong Chen; Qilin Pei; Linfen Tao; Jing Xia; Guocai Lu; Ying Zong; Wenhua Xie; Wanqing Li; Chenglong Huang; Ting Zeng; Xinyu Yu; Weixuan Wang; Gaojun Chen; Song Yang; Rui Cheng; Xi Li
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

8.  Bullatine A exerts anti-inflammatory effects by inhibiting the ROS/JNK/NF-κB pathway and attenuating systemic inflammatory responses in mice.

Authors:  Shuhan Liu; Na Che; Wen Ou; Meichen Yan; Yajin Liao; Yong Cheng
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

9.  Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.

Authors:  Xiaohong Xu; Xiaolin Huang; Liexiang Zhang; Xiaoli Huang; Zihan Qin; Fei Hua
Journal:  BMC Nephrol       Date:  2021-06-10       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.